- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02832141
Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems
January 28, 2019 updated by: Slavko Rogan, Bern University of Applied Sciences
Effect of Thoracic Spine Mobilization on Skin-blood Flow, Erythema and Sympathetic Nervous Systems
This pilot study aims to i) represents the feasibility of the study design and ii) to point out acute effects of thoracic spine mobilization on skin-blood flow, erythema and the sympathetic nervous system.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
14
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3008
- Bern University of Applied Science, Department Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Healthy person between 20 and 30 years.
Description
Inclusion Criteria:
- age 20 - 30 years
- healthy persons
Exclusion Criteria:
- current pain
- blood pressure medications
- osteoporosis
- cardiac or neurological symptoms
- pregnancy
- thromobosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group A
Group A: immediate effects: T0, Grade 3 central thoracic mobilization from posterior-to-anterior on thoracic vertebrae from T5 to T12, immediate (T1), after 2 (T2), 4 (T3), 6 (T4), 8 (T5) and 10 (T6) minutes, 1 days wash-out period; T7, a grade 3 central thoracic mobilization from anterior-to-posterior on all thoracic vertebrae, immediate T8, after 2 (T9), 4 (T10), 6 (T11), 8 (T12) and 10 (T13) minutes.
|
Participant in prone position.
Central thoracic mobilization from posterior-to-anterior.
Other Names:
Participant in sitting position.
Central thoracic mobilization from anteriors-to-posterior.
Other Names:
|
|
Group B
Group B: immediate effects: T0, 3 central thoracic mobilization from anterior-to-posterior on thoracic vertebrae from T5 to T12, immediate (T1), after 2 (T2), 4 (T3), 6 (T4), 8 (T5) and 10 (T6) minutes, 1 days wash-out period; T7, a grade 3-4 central thoracic mobilization from posterior-to-anterior on all thoracic vertebrae, immediate T8, after 2 (T9), 4 (T10), 6 (T11), 8 (T12) and 10 (T13) minutes.
|
Participant in prone position.
Central thoracic mobilization from posterior-to-anterior.
Other Names:
Participant in sitting position.
Central thoracic mobilization from anteriors-to-posterior.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: Adherence of recruited participants
Time Frame: Every 4 weeks up to 2 years
|
Defined as the number of drop-outs and presence of participants which invited.
Measurement unit: number
|
Every 4 weeks up to 2 years
|
|
Feasibility of the investigating procedure
Time Frame: Every 4 weeks up to 2 years
|
Measured the burden of testing procedure.
Measurement units = number and percentage
|
Every 4 weeks up to 2 years
|
|
Feasibility of the mobilization intervention from posterior-to-anterior on thoracic vertebrae
Time Frame: Every 4 weeks up to 2 years
|
Measured adverse effects as pain and harm results to participants.
Measurement units = number and percentage
|
Every 4 weeks up to 2 years
|
|
Feasibility of the mobilization intervention from anterior-to-posterior on thoracic vertebrae
Time Frame: Every 4 weeks up to 2 years
|
Measured as adverse effects as pain and harm results to participants.
Measurement units = number and percentage.
|
Every 4 weeks up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of heart rate variability (HRV)
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
HRV is measured as the variations of the time interval between two consecutive cardiac beats registered by means Polar watch RS800 is used to measures (HRV).
Measurement unit: High frequency-band (HF-Band) and Low frequency-band (LF-Band)
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
|
Rate of systolic blood pressure value (mmHg)
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Omron MIT Elite Plus is used for measuring systolic blood flow.
iMeasurement units: mmHg (millimeter of mercury)
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
|
Rate of diastolic blood pressure value (mmHg) changes
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Omron MIT Elite Plus is used for measuring diastolic blood pressureMeasurement units: mmHg (millimeter of mercury)
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
|
Rate of heartbeat frequency
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Polar watch RS800 is used for measuring heartbeat frequency.
Measurement units: beat per minute (bpm)
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
|
Rate of skin-blood flow variation
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Laser doppler imaging is used for measuring microcirculatory changes.
Measurement units: perfusion unit
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
|
Rate of erythema
Time Frame: Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Tristimulus surface colorimetry is used for measuring erythema.
Measurement units: Erythema index
|
Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jan Taeymans, PhD, Bern University of Applied Science, Departement Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2016
Primary Completion (ACTUAL)
December 31, 2018
Study Completion (ACTUAL)
December 31, 2018
Study Registration Dates
First Submitted
July 2, 2016
First Submitted That Met QC Criteria
July 11, 2016
First Posted (ESTIMATE)
July 14, 2016
Study Record Updates
Last Update Posted (ACTUAL)
January 29, 2019
Last Update Submitted That Met QC Criteria
January 28, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Mobilization Thoracic Spine
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erythema
-
Medicines Development for Global HealthRecruitingErythema Nodosum LeprosumUnited States, Benin, Côte d’Ivoire, Indonesia, Madagascar, Philippines
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompleted
-
Tufts Medical CenterCompleted
-
Acorn Biolabs Inc.RecruitingPost Procedural ErythemaUnited States, Canada
-
VIST - Faculty of Applied SciencesCompletedMinimal Erythema DoseSlovenia
-
University of British ColumbiaUnknownSurgical Scar ErythemaCanada
-
Robert MichelettiCompleted
-
VIST - Faculty of Applied SciencesEuropean Regional Development Fund; Slovenian Research Agency; Valens Int. d.o... and other collaboratorsCompletedDermis Density | Minimal Erythema Dose | Skin ViscoelasticitySlovenia
-
BiocodexRecruiting
-
Skin Laser & Surgery SpecialistsGalderma R&DTerminatedErythema and Flushing Associated With Rosacea
Clinical Trials on Mobilization anterior
-
Federal University of Health Science of Porto AlegreCompletedVertebra; Degeneration | Other Disorders of the Autonomic Nervous SystemBrazil
-
Ain Shams UniversityCompletedSplenic Flexure Mobilization
-
Universidade Federal de Sao CarlosWithdrawnTemporomandibular Joint Dysfunction Syndrome
-
Prince Sattam Bin Abdulaziz UniversityNot yet recruitingAdhesive CapsulitisSaudi Arabia
-
Riphah International UniversityCompletedNon-specific Low Back PainPakistan
-
Isra UniversityUnknownRehabilitation | Prehabilitation | Shoulder ImpingementPakistan
-
Karolinska InstitutetThe Swedish Society of Medicine; The regional agreement on medical training... and other collaboratorsCompletedVaginal ProlapseSweden, Norway, Denmark, Finland
-
Isra UniversityUnknown
-
Riphah International UniversityCompletedLateral EpicondylitisPakistan